Skip to content
Pyramid Biosciences and GeneQuantum Healthcare Announce Preclinical Data for GQ1010, a Potential Best-In-Class TROP2-Targeted Antibody Drug Conjugate, at the 2023 AACR Annual Meeting
1200 US Highway 22 E, Suite 2000-2310, Bridgewater, NJ 08807
Find us on LinkedIn
Developing Transformative Medicines for Patients with Cancer
2023 Pyramid Biosciences, Inc. All Rights Reserved.
Terms & Conditions
by Moxie Design Studios